A 0 1 0 1 O
donor 2 7 2 7 O
liver 8 13 8 13 O
with 14 18 14 18 O
macrosteatosis 19 33 19 33 B-clinical_variable
greater 34 41 34 41 O
than 42 46 42 46 O
40 47 49 47 49 B-lower_bound
% 49 50 49 50 I-lower_bound
if 51 53 51 53 O
biopsy 54 60 54 60 B-treatment
results 61 68 61 68 O
are 69 72 69 72 O
available 73 82 73 82 O

Be 0 2 83 85 O
between 3 10 86 93 O
18 11 13 94 96 B-lower_bound
years 14 19 97 102 I-lower_bound
and 20 23 103 106 O
65 24 26 107 109 B-upper_bound
years 27 32 110 115 I-upper_bound
of 33 35 116 118 O
age 36 39 119 122 B-age

Be 0 2 123 125 O
receiving 3 12 126 135 O
a 13 14 136 137 O
cadaver 15 22 138 145 O
donor 23 28 146 151 O
liver 29 34 152 157 B-treatment
transplant 35 45 158 168 I-treatment

Be 0 2 169 171 O
receiving 3 12 172 181 O
a 13 14 182 183 O
donor 15 20 184 189 O
liver 21 26 190 195 O
with 27 31 196 200 O
a 32 33 201 202 O
cold 34 38 203 207 O
ischemia 39 47 208 216 O
time 48 52 217 221 O
less 53 57 222 226 O
than 58 62 227 231 O
5 63 64 232 233 B-upper_bound
hours 65 70 234 239 I-upper_bound
or 71 73 240 242 O
greater 74 81 243 250 O
than 82 86 251 255 O
12 87 89 256 258 B-lower_bound
hours 90 95 259 264 I-lower_bound

Be 0 2 265 267 O
receiving 3 12 268 277 O
a 13 14 278 279 O
living 15 21 280 286 O
donor 22 27 287 292 O
liver 28 33 293 298 B-treatment
transplant 34 44 299 309 I-treatment

Be 0 2 310 312 O
receiving 3 12 313 322 O
any 13 16 323 326 O
investigational 17 32 327 342 O
drug 33 37 343 347 O
( 38 39 348 349 O
a 39 40 349 350 O
drug 41 45 351 355 O
other 46 51 356 361 O
than 52 56 362 366 O
Treprostinil 57 69 367 379 B-treatment
administered 70 82 380 392 O
under 83 88 393 398 O
an 89 91 399 401 O
IND 92 95 402 405 O
) 95 96 405 406 O
or 97 99 407 409 O
participating 100 113 410 423 O
in 114 116 424 426 O
any 117 120 427 430 O
other 121 126 431 436 B-treatment
investigational 127 142 437 452 I-treatment
study 143 148 453 458 I-treatment
, 148 149 458 459 O
with 150 154 460 464 O
the 155 158 465 468 O
exception 159 168 469 478 O
of 169 171 479 481 O
alemtuzumab 172 183 482 493 B-treatment
( 184 185 494 495 I-treatment
Campath 185 192 495 502 I-treatment
) 192 193 502 503 I-treatment

Be 0 2 504 506 O
receiving 3 12 507 516 O
any 13 16 517 520 O
non 17 20 521 524 O
- 20 21 524 525 O
standard 21 29 525 533 O
immunosuppression 30 47 534 551 B-treatment
protocol 48 56 552 560 O
or 57 59 561 563 O
other 60 65 564 569 O
non 66 69 570 573 O
- 69 70 573 574 O
standard 70 78 574 582 O
treatment 79 88 583 592 O
that 89 93 593 597 O
could 94 99 598 603 O
affect 100 106 604 610 O
interpretation 107 121 611 625 O
of 122 124 626 628 O
the 125 128 629 632 O
study 129 134 633 638 O
results 135 142 639 646 O

Be 0 2 647 649 O
receiving 3 12 650 659 O
any 13 16 660 663 O
prostanoid 17 27 664 674 B-treatment
to 28 30 675 677 O
treat 31 36 678 683 O
portopulmonary 37 51 684 698 B-chronic_disease
hypertension 52 64 699 711 I-chronic_disease

Be 0 2 712 714 O
treated 3 10 715 722 O
in 11 13 723 725 O
accordance 14 24 726 736 O
with 25 29 737 741 O
the 30 33 742 745 O
standard 34 42 746 754 O
of 43 45 755 757 O
care 46 50 758 762 O
protocol(s 51 61 763 773 O
) 61 62 773 774 O
currently 63 72 775 784 O
in 73 75 785 787 O
effect 76 82 788 794 O
for 83 86 795 798 O
liver 87 92 799 804 B-treatment
transplant 93 103 805 815 I-treatment
recipients 104 114 816 826 O
at 115 117 827 829 O
the 118 121 830 833 O
UPMC 122 126 834 838 O
, 126 127 838 839 O
including 128 137 840 849 O
immunosuppression 138 155 850 867 B-treatment
and 156 159 868 871 O
other 160 165 872 877 O
elements 166 174 878 886 O
of 175 177 887 889 O
pre- 178 182 890 894 B-treatment
and 183 186 895 898 I-treatment
post 187 191 899 903 I-treatment
- 191 192 903 904 I-treatment
operative 192 201 904 913 I-treatment
care 202 206 914 918 I-treatment

Be 0 2 919 921 O
undergoing 3 13 922 932 O
multi 14 19 933 938 B-treatment
- 19 20 938 939 I-treatment
organ 20 25 939 944 I-treatment
transplantation 26 41 945 960 I-treatment
( 42 43 961 962 O
transplantation 43 58 962 977 B-treatment
of 59 61 978 980 I-treatment
organs 62 68 981 987 I-treatment
other 69 74 988 993 O
than 75 79 994 998 O
liver 80 85 999 1004 O
at 86 88 1005 1007 O
the 89 92 1008 1011 O
same 93 97 1012 1016 O
time 98 102 1017 1021 O
as 103 105 1022 1024 O
the 106 109 1025 1028 O
liver 110 115 1029 1034 B-treatment
transplantation 116 131 1035 1050 I-treatment
procedure 132 141 1051 1060 I-treatment
) 141 142 1060 1061 O

HIV 0 3 1062 1065 B-chronic_disease
positive 4 12 1066 1074 O

Have 0 4 1075 1079 O
any 5 8 1080 1083 O
known 9 14 1084 1089 O
hypersensitivity 15 31 1090 1106 O
to 32 34 1107 1109 O
prostaglandins 35 49 1110 1124 B-allergy_name
, 49 50 1124 1125 O
prostacyclin 51 63 1126 1138 B-allergy_name
or 64 66 1139 1141 O
treprostinil 67 79 1142 1154 B-allergy_name

Have 0 4 1155 1159 O
been 5 9 1160 1164 O
accepted 10 18 1165 1173 O
as 19 21 1174 1176 O
a 22 23 1177 1178 O
liver 24 29 1179 1184 B-treatment
transplant 30 40 1185 1195 I-treatment
candidate 41 50 1196 1205 O
at 51 53 1206 1208 O
the 54 57 1209 1212 O
University 58 68 1213 1223 O
of 69 71 1224 1226 O
Pittsburgh 72 82 1227 1237 O
Medical 83 90 1238 1245 O
center 91 97 1246 1252 O
( 98 99 1253 1254 O
UPMC 99 103 1254 1258 O
) 103 104 1258 1259 O

Have 0 4 1260 1264 O
fulminant 5 14 1265 1274 B-chronic_disease
hepatic 15 22 1275 1282 I-chronic_disease
failure 23 30 1283 1290 I-chronic_disease

Have 0 4 1291 1295 O
had 5 8 1296 1299 O
a 9 10 1300 1301 O
failed 11 17 1302 1308 O
liver 18 23 1309 1314 B-treatment
transplant 24 34 1315 1325 I-treatment
within 35 41 1326 1332 O
the 42 45 1333 1336 O
previous 46 54 1337 1345 B-upper_bound
180 55 58 1346 1349 I-upper_bound
days 59 63 1350 1354 I-upper_bound

Hepatitis 0 9 1355 1364 B-chronic_disease
C 10 11 1365 1366 I-chronic_disease
positive 12 20 1367 1375 O
donor 21 26 1376 1381 O
liver 27 32 1382 1387 O

Individuals 0 11 1388 1399 O
who 12 15 1400 1403 O
are 16 19 1404 1407 O
allergic 20 28 1408 1416 O
to 29 31 1417 1419 O
iodine 32 38 1420 1426 B-allergy_name

Individuals 0 11 1427 1438 O
who 12 15 1439 1442 O
are 16 19 1443 1446 O
receiving 20 29 1447 1456 O
methylene 30 39 1457 1466 B-treatment
blue 40 44 1467 1471 I-treatment

Model 0 5 1472 1477 B-clinical_variable
for 6 9 1478 1481 I-clinical_variable
end 10 13 1482 1485 I-clinical_variable
stage 14 19 1486 1491 I-clinical_variable
liver 20 25 1492 1497 I-clinical_variable
diseases 26 34 1498 1506 I-clinical_variable
( 35 36 1507 1508 I-clinical_variable
MELD 36 40 1508 1512 I-clinical_variable
) 40 41 1512 1513 I-clinical_variable
score 42 47 1514 1519 I-clinical_variable
of 48 50 1520 1522 O
> 51 52 1523 1524 O
40 53 55 1525 1527 B-lower_bound

On 0 2 1528 1530 O
renal 3 8 1531 1536 B-treatment
replacement 9 20 1537 1548 I-treatment
therapy 21 28 1549 1556 I-treatment
at 29 31 1557 1559 O
the 32 35 1560 1563 O
time 36 40 1564 1568 O
of 41 43 1569 1571 O
study 44 49 1572 1577 O

Those 0 5 1578 1583 O
currently 6 15 1584 1593 O
receiving 16 25 1594 1603 O
treatment 26 35 1604 1613 O
for 36 39 1614 1617 O
portopulmonary 40 54 1618 1632 B-chronic_disease
hypertension 55 67 1633 1645 I-chronic_disease

Those 0 5 1646 1651 O
with 6 10 1652 1656 O
significant 11 22 1657 1668 O
cardiovascular 23 37 1669 1683 B-chronic_disease
disease 38 45 1684 1691 I-chronic_disease
including 46 55 1692 1701 O
treatment 56 65 1702 1711 O
with 66 70 1712 1716 O
inotropes 71 80 1717 1726 B-treatment

